Hongbin Shi
Papers
1
Total Citations
15
H-Index
1
About
Dr. Hongbin Shi is a distinguished urologic surgeon and researcher whose work centers on advancing surgical approaches for bladder cancer treatment. His primary research focus lies in comparing the efficacy and safety of minimally invasive techniques versus traditional open surgery for radical cystectomy. Dr. Shi's most impactful contribution is his landmark 2019 systematic review and meta-analysis, which rigorously evaluated outcomes between minimally invasive radical cystectomy (MIRC) and open radical cystectomy (ORC). This comprehensive study, which has garnered 15 citations, synthesized data from randomized controlled trials to provide evidence-based guidance on surgical decision-making. By systematically analyzing perioperative outcomes, complications, and oncologic efficacy, Dr. Shi has helped clarify the relative benefits and limitations of these competing surgical approaches. His work is particularly valuable for urologists and surgical oncologists navigating the transition toward minimally invasive techniques while ensuring optimal patient outcomes. Through his methodical approach to evidence synthesis, Dr. Shi continues to shape clinical practice in bladder cancer surgery, offering crucial insights that balance innovation with proven surgical standards.
Research Focus
Key Achievements
Top Papers
- 1